Professor Giampiero Favato of Kingston University's Business School added his signature to a recent open letter to 'The Times' from clinicians, scientists and academics with a special interest in the human papillomavirus (HPV) and its associated diseases. The letter published in the paper on 13 June, urges the government to act quickly and extend the national HPV vaccination programme to include adolescent boys.
Gender-neutral vaccinations have been shown to reduce the incidence of life-threatening cancers. Professor Favato has established that it is cost-effective to vaccinate males against the Human Papilloma Virus (HPV virus), overturning the outcome of previous studies and policies.
The letter states "It not only makes sense on a public-health level, but there is now economic evidence to indicate that vaccinating both girls and boys will be cost effective. Such a step would bring the UK into line with Australia, Austria and other countries now recommending HPV vaccination for both sexes."
Previous research by Professor Favato was presented to the Italian Agency for Drug Approval (AIFA). As a result, AIFA changed its vaccination policy for HPV, removing its previous restriction of vaccination to females only and approving vaccination also for males. Find out more about this research.
Find out more about Professor Favato.
Contact:
General enquiries:
Journalists only:
Communications team
Tel: +44 (0)20 8417 3034
Email
Aucun commentaire:
Enregistrer un commentaire